期刊
MUCOSAL IMMUNOLOGY
卷 9, 期 5, 页码 1218-1233出版社
SPRINGERNATURE
DOI: 10.1038/mi.2015.140
关键词
-
类别
资金
- Canadian Institutes for Health Research (CIHR)
- Crohn's and Colitis Canada (CCC)
Intestinal goblet cells are potentially key players in controlling susceptibility to ulcerative colitis (UC). Although impaired mucin (Muc2) production by goblet cells increases microbial stimulation of the colonic mucosa, goblet cells secrete other mediators that may influence or promote UC development. Correspondingly, Muc2-deficient ((-/-)) mice develop spontaneous colitis, concurrent with the dramatic upregulation of the goblet cell mediator, resistin-like molecule-beta (RELM-beta). Testing RELM-beta's role, we generated Muc2(-/-)/Retnlb(-/-) mice, finding that RELM-beta deficiency significantly attenuated colitis development and symptoms compared with Muc2(-/-) mice. RELM-beta expression in Muc2(-/-) mice strongly induced the production/secretion of the antimicrobial lectin RegIII beta, that exerted its microbicidal effect predominantly on Gram-positive Lactobacillus species. Compared with Muc2(-/-)/Retnlb(-/-) mice, this worsened intestinal microbial dysbiosis with a selective loss of colonic Lactobacilli spp. in Muc2(-/-) mice. Orally replenishing Muc2(-/-) mice with murine Lactobacillus spp., but not with a probiotic formulation containing several human Lactobacillus spp. (VSL#3), ameliorated their spontaneous colitis in concert with increased production of short-chain fatty acids. These studies demonstrate that the goblet cell mediator RELM-b drives colitis in Muc2(-/-) mice by depleting protective commensal microbes. The ability of selective commensal microbial replacement to ameliorate colitis suggests that personalized bacterial therapy may prove beneficial for treatment of UC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据